117 related articles for article (PubMed ID: 25755461)
1. Will vitamin d supplementation have a role in the treatment of patients with chronic hepatitis C?
Puri P
J Clin Exp Hepatol; 2012 Dec; 2(4):396-8. PubMed ID: 25755461
[No Abstract] [Full Text] [Related]
2. Efficacy of vitamin D supplementation in combination with conventional antiviral therapy in patients with chronic hepatitis C infection: a meta-analysis of randomised controlled trials.
Kim HB; Myung SK; Lee YJ; Park BJ;
J Hum Nutr Diet; 2018 Apr; 31(2):168-177. PubMed ID: 28833855
[TBL] [Abstract][Full Text] [Related]
3. Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial.
Yokoyama S; Takahashi S; Kawakami Y; Hayes CN; Kohno H; Kohno H; Tsuji K; Aisaka Y; Kira S; Yamashina K; Nonaka M; Moriya T; Kitamoto M; Aimitsu S; Nakanishi T; Kawakami H; Chayama K
J Viral Hepat; 2014 May; 21(5):348-56. PubMed ID: 24716637
[TBL] [Abstract][Full Text] [Related]
4. Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin.
Esmat G; El Raziky M; Elsharkawy A; Sabry D; Hassany M; Ahmed A; Assem N; El Kassas M; Doss W
J Interferon Cytokine Res; 2015 Jan; 35(1):49-54. PubMed ID: 25061714
[TBL] [Abstract][Full Text] [Related]
5. Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection.
Cholongitas E; Theocharidou E; Goulis J; Tsochatzis E; Akriviadis E; Burroughs K
Aliment Pharmacol Ther; 2012 Mar; 35(6):634-46. PubMed ID: 22316435
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.
Bitetto D; Fabris C; Fornasiere E; Pipan C; Fumolo E; Cussigh A; Bignulin S; Cmet S; Fontanini E; Falleti E; Martinella R; Pirisi M; Toniutto P
Transpl Int; 2011 Jan; 24(1):43-50. PubMed ID: 20649944
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D for your patients with chronic hepatitis C?
Rahman AH; Branch AD
J Hepatol; 2013 Jan; 58(1):184-9. PubMed ID: 22871501
[TBL] [Abstract][Full Text] [Related]
8. New insight of vitamin D in chronic liver diseases.
Chen EQ; Shi Y; Tang H
Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):580-5. PubMed ID: 25475859
[TBL] [Abstract][Full Text] [Related]
9. D-livering the message: the importance of vitamin D status in chronic liver disease.
Kitson MT; Roberts SK
J Hepatol; 2012 Oct; 57(4):897-909. PubMed ID: 22634121
[TBL] [Abstract][Full Text] [Related]
10. Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin.
Atsukawa M; Tsubota A; Shimada N; Yoshizawa K; Abe H; Asano T; Ohkubo Y; Araki M; Ikegami T; Okubo T; Kondo C; Osada Y; Nakatsuka K; Chuganji Y; Matsuzaki Y; Iwakiri K; Aizawa Y
Hepatol Res; 2016 Mar; 46(5):450-8. PubMed ID: 26289410
[TBL] [Abstract][Full Text] [Related]
11. Association between vitamin D level and viral load or fibrosis stage in chronic hepatitis B patients from Southern China.
Yu R; Sun J; Zheng Z; Chen J; Fan R; Liang X; Zhu Y; Liu Y; Shen S; Hou J
J Gastroenterol Hepatol; 2015 Mar; 30(3):566-74. PubMed ID: 25238258
[TBL] [Abstract][Full Text] [Related]
12. [Vitamin D and infectious diseases].
Ghosn J; Viard JP
Presse Med; 2013 Oct; 42(10):1371-6. PubMed ID: 24051165
[TBL] [Abstract][Full Text] [Related]
13. 25-Vitamin D levels in chronic hepatitis C infection: association with cirrhosis and sustained virologic response.
Backstedt D; Pedersen M; Choi M; Seetharam A
Ann Gastroenterol; 2017; 30(3):344-348. PubMed ID: 28469365
[TBL] [Abstract][Full Text] [Related]
14. The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients.
Baur K; Mertens JC; Schmitt J; Iwata R; Stieger B; Frei P; Seifert B; Bischoff Ferrari HA; von Eckardstein A; Müllhaupt B; Geier A;
Antivir Ther; 2012; 17(3):541-7. PubMed ID: 22300961
[TBL] [Abstract][Full Text] [Related]
15. Serum Vitamin D levels and Vitamin D supplementation do not correlate with the severity of chronic eczema in children.
Galli E; Rocchi L; Carello R; Giampietro PG; Panei P; Meglio P
Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):41-7. PubMed ID: 25781193
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin.
Refaat B; El-Shemi AG; Ashshi A; Azhar E
Int J Clin Exp Med; 2015; 8(7):10284-303. PubMed ID: 26379820
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis.
Kitson MT; Sarrazin C; Toniutto P; Eslick GD; Roberts SK
J Hepatol; 2014 Dec; 61(6):1247-52. PubMed ID: 25135863
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?
Jin CN; Chen JD; Sheng JF
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):741-746. PubMed ID: 29664746
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D-related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C.
Arai T; Atsukawa M; Tsubota A; Kondo C; Shimada N; Abe H; Itokawa N; Nakagawa A; Okubo T; Aizawa Y; Iwakiri K
J Med Virol; 2015 Nov; 87(11):1904-12. PubMed ID: 25964133
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin.
Murakami Y; Nagai A; Kawakami T; Hino K; Kitase A; Hara Y; Okuda M; Okita K; Okita M
Nutrition; 2006 Feb; 22(2):114-22. PubMed ID: 16459223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
